Patents Examined by Karen S Weiler
-
Patent number: 9701971Abstract: Provided herein are methods of integrating one or more exogenous nucleic acids into one or more selected target sites of a host cell genome. In certain embodiments, the methods comprise contacting the host cell genome with one or more integration polynucleotides comprising an exogenous nucleic acid to be integrated into a genomic target site, and a nuclease capable of causing a double-strand break near or within the genomic target site.Type: GrantFiled: February 11, 2014Date of Patent: July 11, 2017Assignee: AMYRIS, INC.Inventors: Zach Serber, Andrew Horwitz
-
Patent number: 9678080Abstract: Multi-biotinylated reactants are provided which can be used in divalent complexes for various applications such as colocalization, labeling, immobilization, and purification. Methods for constructing, purifying, and using the bis-biotinylated reactants are also provided. In certain embodiments, two bis-biotinylated reactants are bound to a single streptavidin tetramer to provide a complex having a 1:1 stoichiometry with respect to the bis-biotinylated reactants.Type: GrantFiled: June 12, 2014Date of Patent: June 13, 2017Assignee: Pacific Biosciences of California, Inc.Inventors: Erik Miller, Satwik Kamtekar, Keith Bjornson, Jeremiah Hanes
-
Patent number: 9663826Abstract: The present invention relates to a system and method of genomic profiling and is particularly useful in genomic differentiation of heterogeneous and polyclonal neoplastic cell populations, preferably of flow sorted formalin fixed paraffin embedded samples. The present invention includes methods of improving resolution for identifying aberration in variable carcinoma genomes and/or heterogeneous cell populations. The present invention also includes kits configured to improve genomic resolution and the ability to identify genomic aberration in variable and/or heterogeneous cell populations.Type: GrantFiled: February 15, 2013Date of Patent: May 30, 2017Assignee: The Translational Genomics Research InstituteInventors: Michael T. Barrett, Elizabeth Lenkiewicz, Tara Holley
-
Patent number: 9657339Abstract: A method for amplifying a target nucleic acid is disclosed, which includes: (a) fragmenting a nucleic acid sample to create a target fragment comprising a target nucleic acid and two probe-complementary portions; (b) contacting said fragmented nucleic acid sample with a probe comprising two target fragment-complementary portions complementary to the probe-complementary portions of the target fragment; (c) rendering the fragmented nucleic acid sample single-stranded; (d) allowing the probe-complementary portions to hybridise with the target-fragment complementary portions; (e) if the probe in step (b) is not immobilised, immobilising the probe-target fragment hybrid on a solid phase via immobilisation moiety; (f) separating non-immobilised nucleic acid fragments from the solid phase; (g) contacting the solid phase with a ligase to ligate ligatable 5? and 3? ends of the target fragment whereby the target fragment is circularized; and (h) amplifying said circularized target fragment.Type: GrantFiled: December 3, 2010Date of Patent: May 23, 2017Assignee: Agilent Technologies, Inc.Inventors: Fredrik Roos, Henrik Johansson, Magnus Isaksson, Mats Nilsson, Olle (Olof) Ericsson, Simon Fredriksson
-
Patent number: 9650432Abstract: The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies.Type: GrantFiled: January 28, 2011Date of Patent: May 16, 2017Assignee: MORPHOSYS AGInventors: Josef Prassler, David Ott, Stefanie Thiel, Yvonne Stark, Ute Keck, Thomas Pietzonka, Hilmar Ebersbach
-
Patent number: 9587279Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.Type: GrantFiled: November 22, 2013Date of Patent: March 7, 2017Assignee: Cornell UniversityInventors: Thomas J. Fahey, III, Nimmi Kapoor, Theresa Scognamiglio
-
Patent number: 9574231Abstract: Methods for identifying and/or distinguishing a homogeneous population of cells based on their replication domain timing profile using high resolution genomic arrays or sequencing procedures are provided. These methods may be used to compare the replication timing profile for a population of cells to another replication timing profile(s), a replication timing fingerprint, and/or one or more informative segments of a replication timing fingerprint, which may be simultaneously or previously determined and/or contained in a database, to determine whether there is a match between them. Based on such information, the identity of the population of cells may be determined, or the identity of the population of cells may be distinguished from other populations of cells or cell types. Methods for determining a replication timing fingerprint for particular cell types are also provided.Type: GrantFiled: May 2, 2014Date of Patent: February 21, 2017Assignee: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: David M. Gilbert, Tyrone Ryba, Ichiro Hiratani
-
Patent number: 9551035Abstract: The present invention pertains to the field of cancer diagnosis. Specifically, it relates to a method for diagnosing pancreas cancer in a subject comprising the steps of determining in a sample of a subject suspected to suffer from pancreas cancer the amount of at least one biomarker selected from the biomarkers shown in Table 1 and comparing the said amount of the at least one biomarker with a reference, whereby pancreas cancer is to be diagnosed. The present invention also contemplates a method for identifying whether a subject is in need of a pancreas cancer therapy comprising the steps of the aforementioned methods and the further step of identifying a subject in need of a pancreas cancer therapy if said subject is to be diagnosed to suffer from pancreas cancer. Contemplated are, furthermore, diagnostic devices and kits for carrying out said methods.Type: GrantFiled: February 15, 2011Date of Patent: January 24, 2017Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, QUEEN MARY UNIVERSITY OF LONDONInventors: Christoph Schröder, Jörg Hoheisel, Tatjana Crnogorac-Jurcevic
-
Patent number: 9518289Abstract: The present invention relates to a novel method for detection of target nucleic acid sequences by cyclic exonucleolytic reactions (CER) or exonucleolytic reactions (ER) using single-labeled immobilized probes on a solid phase. The present invention enables to detect target nucleic acid sequences on a solid phase using single-labeled systems. Comparing with multiple-labeled systems such as dual labeling, the present invention using single-labeled probes has excellent advantages in light of convenience and cost effectiveness in probe design and preparation. Furthermore, the measurement of changes of the signal decrease during reactions is responsible for more accurate qualitative and quantitative analysis of target nucleic acid sequences.Type: GrantFiled: December 23, 2010Date of Patent: December 13, 2016Assignee: Seegene, Inc.Inventors: Jong Yoon Chun, Young Jo Lee
-
Patent number: 9506913Abstract: The present invention relates to a method of detecting an active tuberculosis infection in a serum sample from an individual. More specifically, the disclosed method uses a single chain variable fragment from a monoclonal immunoglobulin specific for mycolic acids of mycobacterial origin to detect surrogate markers, the presence of which indicate the individual has an active tuberculosis infection. Markers useful for practicing the disclosed method can be serum mycolic acid antigen, serum anti-mycolic acid antibodies or both. In a preferred embodiment, the method is practiced using a lateral flow assay format.Type: GrantFiled: July 12, 2011Date of Patent: November 29, 2016Assignee: University of PretoriaInventors: Jan Adrianus Verschoor, Mervyn Beukes
-
Patent number: 9500636Abstract: This invention provides a multiscale platform for coordinating behavior using synthetic biology. The platform reduces the impact of underlying noise, making outputs more coherent and reliable at the macroscopic level. In one aspect, the invention provides a frequency-modulated biosensor, comprising a microfluidic array comprising two or more separate colonies or populations of sensing cells to grow and communicate by gas exchange, wherein the colonies or populations of sensing cells output synchronized oscillating signals.Type: GrantFiled: December 14, 2012Date of Patent: November 22, 2016Assignee: The Regents of the University of CaliforniaInventors: Arthur Prindle, Phillip Samayoa, Jeff Hasty
-
Patent number: 9493770Abstract: Provided herein are methods, and related compositions for identifying a putative essential gene which serves as an antibiotic target in a bacterium, the method, in some embodiments, comprising (a) generating an antibiotic resistant mutant of the bacterium by a method comprising the step of selecting for growth in the presence of an antibiotic to produce an antibiotic resistant mutant clone (AbR mutant); (b) transforming the AbR mutant with one or more essential genes of the bacterium and a transposon which insertionally inactivates bacterial DNA to produce a pool of transposon mutants which are merodiploid for the one or more essential genes; (c) growing bacteria from the merodiploid pool in the presence of different amounts of the antibiotic to produce two or more test cultures; and (d) comparing the distribution of transposon insertions between the test cultures to identify a putative essential gene serving as a target of the antibiotic in the bacterium.Type: GrantFiled: November 4, 2013Date of Patent: November 15, 2016Assignee: DISCUVA LIMITEDInventors: David Hugh Williams, Arthur Keith Turner
-
Patent number: 9453838Abstract: The present invention provides microarrays that can be analysed by more than one technique using a non-covalent ligand attachment strategy to solid supports such as indium tin oxide (ITO) covered transparent glass slides. This provides, inter alia, glycan arrays on a micrometer scale which allow multimodal readout by MALDI-Tof-MS, fluorescence and optical microscopy. Glycans functionalized with a C5-aminolinker were attached in situ on a picomolar scale to a hydrophobic tag bound to this surface, thus avoiding the wasteful off-chip ligand tagging of other approaches. Glycan arrays prepared using this methodology were analysed both with a fluorescence scanner and by on-chip MALDI-mass spectrometry in a series of glycomics experiments specifically requiring a multimodal readout.Type: GrantFiled: March 11, 2014Date of Patent: September 27, 2016Assignee: Asociación Centro de Investigación Cooperative en BiomaterialesInventors: Ana Beloqui Elizazu, Neils-Christian Reichardt
-
Patent number: 9453218Abstract: The invention relates to a method for producing a DNA sequence for a nucleic acid library having a plurality of elements. The synthesized DNA sequence comprises at least three sections. The first section and the third section in each element have defined sequences (D1, D2) that are identical in each element of the nucleic acid library. In a middle second section, at least two adjoining variable codon triplets are arranged.Type: GrantFiled: February 14, 2013Date of Patent: September 27, 2016Inventor: Markus Fuhrmann
-
Patent number: 9447411Abstract: Methods of obtaining a single cell expression profile from a target mammalian cell are provided. Aspects of the methods include contacting a cellular sample which includes the target mammalian cell with a packaged viral barcoded trans-splicing library including a plurality of barcoded trans-splicing constructs under transduction conditions, where a barcoded trans-splicing construct includes a trans-splicing element linked to a barcode element. The methods further include generating expression data from the resultant transduced target mammalian cell to obtain the single cell expression data from the target mammalian cell. Also provided are compositions, e.g., libraries and components thereof, which find use in practicing the methods.Type: GrantFiled: January 13, 2014Date of Patent: September 20, 2016Assignee: Cellecta, Inc.Inventor: Alex Chenchik
-
Patent number: 9434771Abstract: The present invention features biomarkers capable of diagnosing inflammatory bowel disease and methods of using such biomarkers to diagnose and selecting treatments for inflammatory bowel diseases.Type: GrantFiled: December 17, 2009Date of Patent: September 6, 2016Assignee: The Johns Hopkins UniversityInventors: Xuhang Li, Heng Zhu
-
Patent number: 9428769Abstract: A liposome comprising a region of a lipid bilayer membrane with different membrane thicknesses, wherein each lipid bilayer membrane region is composed of a different lipid, and a thick membrane side in the region of the lipid bilayer membrane is formed of lipid having a phase transition temperature higher than that of the lipid forming a thin membrane side in the region of the lipid bilayer membrane. A proteoliposome, wherein the above-described liposome includes membrane proteins. A biochip, wherein the above-described liposome or the above-described proteoliposome is spread on a substrate. The above-described biochip, wherein the substrate includes at least one kind selected from the group consisting of mica, SiO2, SiN, Au and Pt.Type: GrantFiled: November 26, 2008Date of Patent: August 30, 2016Assignees: Nippon Telegraph and Telephone Corporation, Isis Innovation Ltd.Inventors: Chandra Sekar Ramanujan, Nahoko Kasai, Keiichi Torimitsu, John F. Ryan
-
Patent number: 9388465Abstract: The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing. In some cases, this disclosure provides methods for the generation of polynucleotide barcode libraries, and for the attachment of such polynucleotides to target polynucleotides.Type: GrantFiled: February 7, 2014Date of Patent: July 12, 2016Assignee: 10X GENOMICS, INC.Inventors: Benjamin Hindson, Mirna Jarosz, Paul Hardenbol, Michael Schnall-Levin, Kevin Ness, Serge Saxonov
-
Patent number: 9322045Abstract: The present invention relates to a recombinant host cell for the production of a compound of interest. The invention further relates to a method for the production of such host cell. The invention further relates to the production of a compound of interest. The invention further relates to isolated polynucleotides and vectors and host cells comprising said polynucleotides.Type: GrantFiled: April 10, 2014Date of Patent: April 26, 2016Assignee: DSM IP ASSETS B.V.Inventors: Noël Nicolaas Maria Elisabeth Van Peij, Herman Jan Pel, Thibaut José Wenzel, Adriana Marina Riemens, Ilse De Lange
-
Patent number: 9309511Abstract: Provided herein are compositions and methods for assaying the deleteriousness of putative loss-of-function mutations, especially in genes known to be or suspected of being tumor-suppressor genes. The invention includes syngeneic variance libraries and methods of construction and use of syngeneic variance libraries.Type: GrantFiled: August 28, 2008Date of Patent: April 12, 2016Assignee: The Johns Hopkins UniversityInventors: Scott E. Kern, Eike Gallmeier, Tomas Hucl